Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study
-
Published:2024-10
Issue:
Volume:90
Page:105790
-
ISSN:2211-0348
-
Container-title:Multiple Sclerosis and Related Disorders
-
language:en
-
Short-container-title:Multiple Sclerosis and Related Disorders
Author:
Zeineddine MayaORCID,
Al-Hajje Amal,
Salameh Pascale,
Massouh Joelle,
Saab Georges,
Al-Roughani Raed,
Ahmed Samar Farouk,
Al-Mahdawi Akram,
Shalaby Nevin,
Inshasi Jihad,
Sahraian Mohamad Ali,
Gouider Riadh,
Mrabet Saloua,
Al-Khabouri Jaber,
Shayganneja Vahid,
Chentouf Amina,
Boumediene Farid,
Yamout BassemORCID